Amer Renal Assoc Stock Return On Equity
Amer Renal Assoc fundamentals help investors to digest information that contributes to Amer Renal's financial success or failures. It also enables traders to predict the movement of Amer Stock. The fundamental analysis module provides a way to measure Amer Renal's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Amer Renal stock.
Amer |
Amer Renal Assoc Company Return On Equity Analysis
Amer Renal's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Amer Renal Return On Equity | 17.51 |
Most of Amer Renal's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amer Renal Assoc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Amer Renal Assoc has a Return On Equity of 17.51. This is 173.05% lower than that of the Healthcare sector and notably lower than that of the Diagnostics & Research industry. The return on equity for all United States stocks is notably lower than that of the firm.
Amer Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amer Renal's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Amer Renal could also be used in its relative valuation, which is a method of valuing Amer Renal by comparing valuation metrics of similar companies.Amer Renal is currently under evaluation in return on equity category among its peers.
Amer Fundamentals
| Return On Equity | 17.51 | |||
| Return On Asset | 4.35 | |||
| Profit Margin | (1.11) % | |||
| Operating Margin | 9.73 % | |||
| Current Valuation | 1.26 B | |||
| Shares Outstanding | 34.54 M | |||
| Shares Owned By Insiders | 9.15 % | |||
| Shares Owned By Institutions | 80.77 % | |||
| Number Of Shares Shorted | 608.63 K | |||
| Price To Earning | 144.04 X | |||
| Price To Book | (20.05) X | |||
| Price To Sales | 0.49 X | |||
| Revenue | 814.1 M | |||
| Gross Profit | 254.5 M | |||
| EBITDA | 113.52 M | |||
| Net Income | (16.86 M) | |||
| Cash And Equivalents | 126.9 M | |||
| Cash Per Share | 3.68 X | |||
| Total Debt | 724.51 M | |||
| Debt To Equity | 3.94 % | |||
| Current Ratio | 1.05 X | |||
| Book Value Per Share | (2.33) X | |||
| Cash Flow From Operations | 174.15 M | |||
| Short Ratio | 3.91 X | |||
| Earnings Per Share | (0.52) X | |||
| Price To Earnings To Growth | 2.41 X | |||
| Number Of Employees | 4.98 K | |||
| Beta | 1.11 | |||
| Market Capitalization | 397.94 M | |||
| Total Asset | 938.28 M | |||
| Retained Earnings | (192.31 M) | |||
| Working Capital | 96.27 M | |||
| Current Asset | 193.75 M | |||
| Current Liabilities | 97.47 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Amer Stock
If you are still planning to invest in Amer Renal Assoc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amer Renal's history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |